… blood cancer. In the present review, we will provide an overview of CXCR4-directed molecular
… patients and, thus, may even provide a more reliable read-out of ongoing inflammatory …

… theranostics in cancer, this review primarily focuses on imaging of a broad spectrum of
inflammatory … on macrophages and T cells, CXCR4-directed molecular imaging provides the …

… The objective of this study was to synthesize theranostic molecular tracers with superior
CXCR4 targeting functions. The Daudi cell line, which highly expressed CXCR4, and the MM.1S …

… expression of CCR4 in human gastric cancer. Feasibly suppressing CCR4 expression …
Radiation produces pro-inflammatory factors to recruit TILs and change the inflammatory …

… in cancer and inflammation as well as CXCR4-targeted radioligand therapy (RLT) have
recently found their way into clinical research by the development of the theranostic agents [ 68 …

… These include its inability to differentiate inflammatory/infectious pathologies from tumor …
serve as a prerequisite for potential CXCR4-directed radio-chemotherapies. In a preliminary …

… theranostics (5). Currently there are phase 1 clinical trials testing CXCR4 targeted radionuclides
for cancer … blinded pathologist for tubuloninterstitial inflammation, interstitial fibrosis, and …

… inflammatory diseases, and metastatic cancer, including breast cancer, gastric cancer, and
non-small cell lung cancer… possibility of this radiotracer pair as a theranostic pair [64]. Further, …

… in oncology, cardiology and inflammatory disease. Preclinical work in various cancer cell …
clinical exploration with potential for theranostic applications in hematologic malignancies. …

… of CXCR4-directed … Oncology in 2022, an expert panel of hematooncologists and nuclear
medicine physicians discussed potential clinical applications of CXCR4-targeted theranostics. …